IP Library › Granted Patent US 12,727,827
Granted Patent B2
US 12,727,827 · App. 18/316,954 · Granted Sep 8, 2026

Gastric resident electronics

Inventors: Robert S. Langer (Newton, MA); Carlo Giovanni Traverso (Newton, MA); Yong Lin Kong (Salt Lake City, UT)
Assignees: Massachusetts Institute of Technology; The Brigham and Women's Hospital, Inc.
A61B5/6885A61B5/0031A61B5/073A61B5/4238A61B5/6861A61B5/6871A61M31/002A61B2560/0443A61B2562/0285A61B2562/162A61M2205/0216A61M2205/0272A61M2205/3523A61M2210/1053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,827
App. No.
18/316,954
Granted
Sep 8, 2026
Kind
B2
Abstract

Gastric resident electronics, devices, systems, and related methods are generally provided. Some embodiments comprise administering (e.g., orally) an (electronic) resident structure to a subject (e.g., a patient) such that the (electronic) resident structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before exiting said location internal to the subject. In some embodiments, the resident structure is a gastric resident electronic. That is to say, in some embodiments, the resident structure is configured for relatively long gastric residence and comprises an electronic component. In some embodiments, the structures and components described herein may comprise one or more components configured for the delivery of an active substance(s) (e.g., a pharmaceutical agent) to the subject. In some embodiments, the device has a modular design, combining an electronic component(s) with materials configured for controlled and/or tunable degradation/dissolution to determine the time at which (gastric) residence is lost and the device exits the location internal to the subject. For example, in some embodiments, the resident structure comprises an electronic component and one or more additional components associated with the electronic component such that the resident structure is configured to be retained at a location internal to a subject for greater than or equal to 24 hours.

Claims (45)

1 . A gastric resident structure, comprising:

an elastic core;

three or more polymeric arms extending radially from the elastic core; and

a separate degradable linker coupling at least one of the three or more polymeric arms to the elastic core,

wherein at least one of the three or more polymeric arms comprises an electronic component, and

wherein at least one of the polymeric arms is configured to separate from the electronic component.

2 . A gastric resident structure configured for oral administration, comprising:

an elastic core;

three or more polymeric arms extending radially from the elastic core; and

an electronic component,

wherein at least one of the three or more polymeric arms comprises an electronic component,

wherein the gastric resident structure is configured such that it is retained at a location internally of a subject for at least about 24 hours, wherein the location internally of the subject is a stomach of the subject, and

wherein at least one of the polymeric arms is configured to separate from the electronic component.

3 . A gastric resident structure configured for transmission of a signal extra-corporeally, comprising:

an elastic core,

three or more polymeric arms extending radially from the elastic core,

an electronic component comprising a wireless transmitter,

wherein at least one of the three or more polymeric arms comprises the electronic component,

wherein the gastric resident structure is configured such that it is administered orally and retained at a location internal to a subject adjacent the pylorus of a subject for at least about 24 hours, wherein the location internally of the subject is a stomach of the subject,

wherein the wireless transmitter is configured to transmit a signal from the location internal to the subject to a receiver positioned extracorporeal of the subject, and

wherein at least one of the polymeric arms is configured to separate from the electronic component.

4 . The gastric resident structure as in claim 1 , comprising a pharmaceutical agent associated with the electronic component.

5 . The gastric resident structure as in claim 4 , wherein at least a portion of the pharmaceutical agent is configured to be released upon a signal received from the electronic component.

6 . A method for delivering an electronic component to a subject, comprising:

administering orally, to a subject, a gastric resident structure comprising an electronic component such that the electronic component is retained at a location internal to the subject for at least about 24 hours, wherein the location internal to the subject is a stomach of the subject,

wherein the gastric resident structure comprises an elastic core, three or more polymeric arms extending radially from the elastic core,

wherein one of the three or more polymeric arms comprises the electronic component, and

wherein at least one of the polymeric arms is configured to separate from the electronic component.

7 . The method as in claim 6 , wherein the gastric resident structure comprises a degradable linker.

8 . The method as in claim 7 , further comprising removing the electronic component from the location internal to the subject by degrading the degradable linker.

9 . The method as in claim 8 , wherein degrading the degradable linker comprises applying, via the electronic component, a voltage to the degradable linker.

10 . The method as in claim 9 , wherein the degradable linker comprises a plurality of carbonaceous particles, carbon nanotubes, and/or conductive particles.

11 . The gastric resident structure as in claim 2 , wherein the location internal to the subject is the stomach.

12 . The gastric resident structure as in claim 2 , wherein the location internal to the subject is proximate the pylorus.

13 . The gastric resident structure as in claim 1 , wherein the degradable linker comprises a plurality of carbonaceous particles, carbon nanotubes, and/or conductive particles.

14 . The gastric resident structure as in claim 1 , wherein the electronic component is configured to apply a voltage to the degradable linker.

15 . The gastric resident structure as in claim 1 , wherein the degradable linker is configured to degrade in the presence of a voltage.

16 . The gastric resident structure as in claim 1 , wherein the degradable linker is configured to degrade in the presence of a generated increase in temperature.

17 . The gastric resident structure as in claim 1 , wherein the degradable linker degrades, dissolves, disassociates, or mechanically weakens in a gastric environment which results in loss of retention shape integrity and passage out of a gastric cavity.

18 . The gastric resident structure as in claim 1 , wherein the three or more polymeric arms are configured to maintain structural integrity during a residence period of the gastric resident structure.

19 . The gastric resident structure as in claim 1 , further comprising a containing structure.

20 . The gastric resident structure as in claim 19 , wherein the gastric resident structure is constructed and arranged to have a first configuration when contained within the containing structure and a second configuration after release from the containing structure.

21 . The gastric resident structure as in claim 1 , wherein the electronic component comprises a wireless transmitter.

22 . The gastric resident structure as in claim 1 , wherein the electronic component comprises a pharmaceutical agent configured for release at a location internal to a subject.

23 . The gastric resident structure as in claim 19 , wherein the gastric resident structure is constructed and arranged to undergo elastic recoil upon release from the containing structure, the gastric resident structure having a first configuration when contained within the containing structure and a second configuration after release from the containing structure.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jan 23, 2024
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066363/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2023
From: LANGER, ROBERT S.; KONG, YONG LIN
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 064608/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2023
From: TRAVERSO, CARLO GIOVANNI
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Reel/Frame 064608/0488 →
Continuity (3)
Division 16202647 · Nov 28, 2018
Provisional Application 62591556 · Nov 28, 2017
Related Publication 20230380768A1 · Nov 30, 2023
References Cited (104)
US 4844076A · Lesho et al. · 1989 [cited by applicant]
US 5002772A · Curatolo · 1991 [cited by examiner]
US 5318557A · Gross · 1994 [cited by applicant]
US 5792048A · Schaefer · 1998 [cited by applicant]
US 6804558B2 · Haller et al. · 2004 [cited by applicant]
US 7039453B2 · Mullick et al. · 2006 [cited by applicant]
US 7253716B2 · Lovoi et al. · 2007 [cited by applicant]
US 8036731B2 · Kimchy et al. · 2011 [cited by applicant]
US 8048169B2 · Burnett et al. · 2011 [cited by applicant]
US 8125516B2 · Iddan et al. · 2012 [cited by applicant]
US 8836513B2 · Hafezi et al. · 2014 [cited by applicant]
US 9270025B2 · Robertson · 2016 [cited by examiner]
US 9985320B2 · Bettinger et al. · 2018 [cited by applicant]
US 10521561B1 · Euliano · 2019 [cited by examiner]
US 11684315B2 · Langer et al. · 2023 [cited by applicant]
US 11992552B2 · Bellinger · 2024 [cited by examiner]
US 20010051766A1 · Gazdzinski · 2001 [cited by applicant]
US 20050055039A1 · Burnett et al. · 2005 [cited by applicant]
US 20060122954A1 · Podlasek · 2006 [cited by applicant]
US 20070123809A1 · Weiss · 2007 [cited by examiner]
US 20100137686A1 · Meron et al. · 2010 [cited by applicant]
US 20110257491A1 · Robertson et al. · 2011 [cited by applicant]
US 20130310664A1 · Kozloski et al. · 2013 [cited by applicant]
US 20150051589A1 · Sako et al. · 2015 [cited by applicant]
US 20150118526A1 · Bettinger et al. · 2015 [cited by applicant]
US 20160367790A1 · Belenky · 2016 [cited by examiner]
US 20200281851A1 · Grant et al. · 2020 [cited by applicant]
CN 102370453A · 2012 [cited by applicant]
WO WO2005079384A2 · 2005 [cited by applicant]
WO WO2009063375A1 · 2009 [cited by applicant]
WO WO2013145855A1 · 2015 [cited by applicant]
WO WO2015191920 · 2015 [cited by examiner]
WO WO2015191920A1 · 2015 [cited by applicant]
WO WO2018102799A1 · 2018 [cited by applicant]
International Search Report and Written Opinion mailed Feb. 19, 2019, for Application No. PCT/US2018/062728. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2018/062728, mailed Jun. 11, 2020. [cited by applicant]
Abid, Ingestible Electronics Without Batteries: Wireless Power and Communication for Gastroresident Devices. 2016 MIT Master's Thesis. Department of Electrical Engineering and Computer Science, Massachusetts Institute o… [cited by applicant]
Abid et al., Wireless power transfer to millimeter-sized gastrointestinal electronics validated in swine model. Sci Rep. Apr. 27, 2017;7:46745(1-6). doi: 10.1038/srep46745. [cited by applicant]
Agrawal et al., Conformal phased surfaces for wireless powering of bioelectronic microdevices. Nat Biomed Eng. 2017;1:0043 (1-9). doi: 10.1038/s41551-017-0043. Epub Mar. 6, 2017. [cited by applicant]
Anderson, Mechanisms of inflammation and infection with implanted devices. Ch. 4 in Cardiovasc Pathol. Jul.-Sep. 1993;2(3)(Suppl):33s-41s. [cited by applicant]
Aoyagi et al., Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits. J Pharm Sci. Dec. 1992;81(12):1170-4. [cited by applicant]
Awasthi et al., Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378-394. doi: 10.3109/10717544.2014.936535. Epub Ju… [cited by applicant]
Bellinger et al., Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals. Sci Transl Med. Nov. 16, 2016;8(365):365ra157(1-12). [cited by applicant]
Benabid et al., Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol. Jan. 2009;8(1):67-81. doi: 10.1016/S1474-4422(08)70291-6. [cited by applicant]
Bettinger et al., Materials advances for next-generation ingestible electronic medical devices. Trends Biotechnol. Oct. 2015;33(10):575-585. doi: 10.1016/j.tibtech.2015.07.008. Epub Sep. 21, 2015. [cited by applicant]
Cassilly et al., Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil. Apr. 2008;20… [cited by applicant]
Dagdeviren et al., Miniaturized neural system for chronic, local intracerebral drug delivery. Sci Transl Med. Jan. 24, 2018;10(425):eaan2742(1-10). doi: 10.1126/scitranslmed.aan2742. [cited by applicant]
Darouiche, Treatment of infections associated with surgical implants. Engl J Med. Apr. 1, 2004;350(14):1422-9. [cited by applicant]
De Bakey et al., Bezoars and concretions: Comprehensive review of literature, with analysis of 303 collected cases and presentation of eight additional cases. Part 1. Surgery. Dec. 1938;4(6):934-63. [cited by applicant]
Del Pozo et al., Clinical practice. Infection associated with prosthetic joints. Engl Med. Aug. 20, 2009;361(8):787-94. doi: 10.1056/NEJMcp0905029. [cited by applicant]
Eilenberg et al., Control of a powered ankle-foot prosthesis based on a neuromuscular model. IEEE Trans Neural Syst Rehabil Eng. Apr. 2010;18(2):164-73. doi: 10.1109/TNSRE.2009.2039620. Epub Jan. 12, 2010. [cited by applicant]
Eng et al., Gastrointestinal bezoars: history and current treatment paradigms. Gastroenterol Hepatol (N Y). Nov. 2012;8(11):776-8. [cited by applicant]
Evans et al., Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. Aug. 1988;29(8):1035-41. [cited by applicant]
Farra et al., First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med. Feb. 22, 2012;4(122):122ra21(1-10). doi: 10.1126/scitranslmed.3003276. Epub Feb. 16, 2012. [cited by applicant]
Gao et al., Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis. Nature. Jan. 28, 2016;529(7587):509-514. Suppl Info . doi: 10.1038/nature16521. [cited by applicant]
Ghosh et al., Addressing unmet clinical needs with 3D printing technologies. Adv Healthc Mater. Sep. 2018;7(17):1800417(1-24). doi: 10.1002/adhm.201800417. Epub Jul. 13, 2018. [cited by applicant]
Gordi et al., Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive-extended-release and immediate-release tablets: a randomized, open-label, multiple-do… [cited by applicant]
Gorter et al., Management of trichobezoar: case report and literature review. Pediatr Surg Int. May 2010;26(5):457-63. doi: 10.1007/s00383-010-2570-0. Epub Mar. 6, 2010. [cited by applicant]
Grayson et al., Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater. Nov. 2003;2(11):767-72. Epub Oct. 19, 2003. [cited by applicant]
Hafezi et al., An ingestible sensor for measuring medication adherence. IEEE Trans Biomed Eng. Jan. 2015;62(1):99-109. [cited by applicant]
Iddan et al., Wireless capsule endoscopy. Nature. May 25, 2000;405(6785):417-418. [cited by applicant]
Imaz et al., Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. Jul. 2008;18(7):841-6. doi: 10.1007/s11695-007-9331-8. Epub May 6, 2008. [cited by applicant]
Kalantar-Zadeh et al., A human pilot trial of ingestible electronic capsules capable of sensing different gases in the gut. Nat Electron. Jan. 2018;1:79-87. [cited by applicant]
Kim et al., Epidermal electronics. Science. Aug. 12, 2011;333(6044):838-843. Erratum 1pg. doi: 10.1126/science.1206157. [cited by applicant]
Kirschenbaum et al., Heartfelt Swallow: Management of a Case of Multiple Ingested Foreign Bodies. Sep. 2017. Crsls Mis Case Report from SLS.org, e2017.0004 (1-5). [cited by applicant]
Kirtane et al., Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nat Commun. Jan. 9, 2018;9(2):1-12. doi: 10.1038/s41467-017-02294-6. [cited by applicant]
Klug et al., Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. Sep. 18, 2007;116(12):1349-55. Epub Aug. 27, 2007. [cited by applicant]
Kong et al., 3D-printed gastic resident electronics. Adv Mater Technol. 2019;1800490(1-11). doi: 10.1002/admt.201800490. [cited by applicant]
Laulicht et al., Understanding gastric forces calculated from high-resolution pill tracking. Proc Natl Acad Sci U S A. May 4, 2010;107(18):8201-6. doi: 10.1073/pnas.1002292107. Epub Apr. 19, 2010. [cited by applicant]
Laulicht et al., Simple battery armor to protect against gastrointestinal injury from accidental ingestion. Proc Natl Acad Sci U S A. Nov. 18, 2014;111(46):16490-5. doi: 10.1073/pnas.1418423111. Epub Nov. 3, 2014. [cited by applicant]
Lavine et al., If I only had a . . . Science Feb. 8, 2002;295(5557):995. [cited by applicant]
Lee et al., Implantable batteryless device for on-demand and pulsatile insulin administration. Nat Commun. Apr. 13, 2017;8:15032(1-10). doi: 10.1038/ncomms15032. [cited by applicant]
Liu et al., Triggerable tough hydrogels for gastric resident dosage forms. Nat Commun. Jul. 25, 2017;8(1):124(1-10). doi: 10.1038/s41467-017-00144-z. [cited by applicant]
Mandal et al., Gastro-retentive drug delivery systems and their in vivo success: A recent update. Asian J Pharm Sci. Oct. 2016; 11(5): 575-84. [cited by applicant]
Maqbool et al., Wireless capsule motility: comparison of the SmartPill GI monitoring system with scintigraphy for measuring whole gut transit. Dig Dis Sci. Oct. 2009;54(10):2167-74. doi: 10.1007/s10620-009-0899-9. Epub … [cited by applicant]
Medani et al., Small bowel obstruction secondary to migration of a fragment of lithobezoar: a case report. Cases J. Dec. 7, 2009;2:9155(1-3). doi: 10.1186/1757-1626-2-9155. [cited by applicant]
Mimee et al., An ingestible bacterial-electronic system to monitor gastrointestinal health. Science. May 25, 2018;360(6391):915-918(1-4). doi: 10.1126/science.aas9315. [cited by applicant]
Mintchev et al., Pilot study of temporary controllable gastric pseudobezoars for dynamic non-invasive gastric volume reduction. Physiol Meas. Feb. 2010;31(2):131-44. doi: 10.1088/0967-3334/31/2/001. Epub Dec. 11, 2009. [cited by applicant]
Moore et al., Beyond cochlear implants: awakening the deafened brain. Nat Neurosci. Jun. 2009;12(6):686-91. doi: 10.1038/nn.2326. Epub May 26, 2009. [cited by applicant]
Nadeau et al., Prolonged energy harvesting for ingestible devices. Nat Biomed Eng. 2017;1:0022(1-8). doi: 10.1038/s41551-016-0022. Epub Feb. 6, 2017. [cited by applicant]
Nathan et al., An implantable synchronous pacemaker for the long term correction of complete heart block. Am J Cardiol. Mar. 1963;11(3):362-7. [cited by applicant]
Phillips et al., Gastric trichobezoar: case report and literature review. Mayo Clin Proc. Jul. 1998;73(7):653-6. [cited by applicant]
Prausnitz et al., Transdermal drug delivery. Nat Biotechnol. Nov. 2008;26(11):1261-8. doi: 10.1038/nbt.1504. [cited by applicant]
Prescott et al., Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol. Apr. 2006;24(4):437-8. Epub Mar. 12, 2006. [cited by applicant]
Reefhuis et al., Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. Jul. 31, 2003;349(5):435-45. [cited by applicant]
Salessiotis, Measurement of the diameter of the pylorus in man. I. Experimental project for clinical application. Am J Surg. Sep. 1972;124(3):331-3. [cited by applicant]
Santini et al., A controlled-release microchip. Nature. Jan. 28, 1999;397(6717):335-8. [cited by applicant]
Sarna et al., Gastric pacemakers. Gastroenterology. Feb. 1976;70(2):226-31. [cited by applicant]
Schierholz et al., Implant infections: a haven for opportunistic bacteria. J Hosp Infect. Oct. 2001;49(2):87-93. [cited by applicant]
Schork, Personalized medicine: Time for one-person trials. Nature. Apr. 29, 2015;520(7549):609-11. doi: 10.1038/520609a. retrieved from the internet at http://www.nature.com/news/personalized-medicine . . . Apr. 30, 201… [cited by applicant]
Silva et al., Implantable loop recorder monitoring for refining management of children with inherited arrhythmia syndromes. J Am Heart Assoc. May 26, 2016;5(6):003632(1-9). doi: 10.1161/JAHA.116.003632. accessed online … [cited by applicant]
Snoeck et al., Gastrointestinal transit time of nondisintegrating radio-opaque pellets in suckling and recently weaned piglets. J Control Release. Jan. 8, 2004;94(1):143-53. [cited by applicant]
Stack et al., Pharmacobezoar: an evolving new entity. Dig Dis. Nov.-Dec. 1995;13(6):356-64. [cited by applicant]
Traverso et al., Perspective: Special delivery for the gut. Nature. Mar. 26, 2015;519(7544):S19. doi: 10.1038/519S19a. [cited by applicant]
Tripathi et al., Current State and Future Perspectives on Gastroretentive Drug Delivery Systems. Pharmaceutics. Apr. 20, 2019;11(4):193. [cited by applicant]
Tsesmeli et al., Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy. Dec. 2009;41(12):1082-9. doi: 10.1055/s-0029-1215269. Epub Nov. 6, 2009. [cited by applicant]
Uhrich et al., Polymeric systems for controlled drug release. Chem Rev. Nov. 10, 1999;99(11):3181-98. [cited by applicant]
Van Der Schaar et al., A novel ingestible electronic drug delivery and monitoring device. Gastrointest Endosc. Sep. 2013;78(3):520-8. doi: 10.1016/j.gie.2013.03.170. Epub May 14, 2013. [cited by applicant]
Veiseh et al., Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater. Jun. 2015;14(6):643-51. doi: 10.1038/nmat4290. Epub May 18, 2015. Suppl Info, 1 … [cited by applicant]
Waltz, Drugs go wireless. Nat Biotechnol. Jan. 2016;34(1):15-8. doi: 10.1038/nbt.3446. [cited by applicant]
Watson et al., Telemetering from within the body using a pressure-sensitive radio pill. Gut. Jun. 1962;3:181-6. [cited by applicant]
Zhang et al., A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices. Nat Mater. Oct. 2015;14(10):1065-71. doi: 10.1038/nmat4355. Epub Jul. 27, 2015. Adv online publication, 9 page… [cited by applicant]
Zrenner et al., Fighting blindness with microelectronics. Sci Transl Med. Nov. 6, 2013;5(210):210ps16(1-7). doi: 10.1126/scitranslmed.3007399. [cited by applicant]
Zworykin et al., A Radio Pill. Nature. May 4, 1957;179:898. 1 page. [cited by applicant]